| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | MLN4924 | CTRPv2 | pan-cancer | AAC | 0.055 | 0.1 |
| mRNA | JQ-1:MK-0752 (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.055 | 0.1 |
| mRNA | paclitaxel | CTRPv2 | pan-cancer | AAC | 0.053 | 0.1 |
| mRNA | Docetaxel | CTRPv2 | pan-cancer | AAC | 0.079 | 0.1 |
| mRNA | trifluoperazine | CTRPv2 | pan-cancer | AAC | 0.062 | 0.1 |
| mRNA | MLN2480 | CTRPv2 | pan-cancer | AAC | 0.086 | 0.1 |
| mRNA | PF-3758309 | CTRPv2 | pan-cancer | AAC | 0.069 | 0.1 |
| mRNA | BRD-K30019337 | CTRPv2 | pan-cancer | AAC | -0.11 | 0.1 |
| mRNA | parbendazole | CTRPv2 | pan-cancer | AAC | 0.048 | 0.1 |
| mRNA | ML203 | CTRPv2 | pan-cancer | AAC | -0.059 | 0.1 |